Publications

BibTex format

@inproceedings{Popat:2022,
author = {Popat, S and Felip, E and Kim, ES and de, Marinis F and Cho, BC and Wermke, M and De, langen A and Ferrara, R and Kanzler, S and Cecere, FL and Galetta, D and Lee, DH and Gregorc, V and Rodrigues, A and Britschgi, C and Rahman, A and Ndunda, D and Noe, J and Lu, D and Besse, B},
publisher = {LIPPINCOTT WILLIAMS & WILKINS},
title = {AcceleRET Lung: A phase 3 study of first-line pralsetinib in patients with <i>RET</i> fusion-positive advanced/metastatic NSCLC.},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000863680305143&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2022}
}

Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Popat,S
AU  - Felip,E
AU  - Kim,ES
AU  - de,Marinis F
AU  - Cho,BC
AU  - Wermke,M
AU  - De,langen A
AU  - Ferrara,R
AU  - Kanzler,S
AU  - Cecere,FL
AU  - Galetta,D
AU  - Lee,DH
AU  - Gregorc,V
AU  - Rodrigues,A
AU  - Britschgi,C
AU  - Rahman,A
AU  - Ndunda,D
AU  - Noe,J
AU  - Lu,D
AU  - Besse,B
PB  - LIPPINCOTT WILLIAMS & WILKINS
PY  - 2022///
SN  - 0732-183X
TI  - AcceleRET Lung: A phase 3 study of first-line pralsetinib in patients with <i>RET</i> fusion-positive advanced/metastatic NSCLC.
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000863680305143&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -

Download

DrSanjayPopat

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)